NCT03852355View on ClinicalTrials.gov

the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

September 10, 2019

Study Completion Date

October 25, 2019

Conditions
Rheumatoid ArthritisHeadache
Interventions
DRUG

Radiofrequency

), received bilateral 3rd occipital nerve RF under fluoroscopic guidance. Levobupivacaine (0.3 mL; 0.75%) and triamcilonone (1 mg) were injected at each level

DRUG

Steroids

received systemic steroids oral prednisolone tablet, 10 mg/day

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03852355 - the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter